CNS Pharmaceuticals, Inc.

IN THE PRESS

Press Releases

CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum

February 20, 2025

·

2 min read

Press Releases

CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

February 19, 2025

·

3 min read

Press Releases

CNS Pharmaceuticals Announces Reverse Stock Split

February 19, 2025

·

4 min read

Press Releases

CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit

February 19, 2025

·

5 min read

Press Releases

CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference

February 10, 2025

·

2 min read

Press Releases

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024

December 5, 2024

·

3 min read

Press Releases

CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy

November 25, 2024

·

7 min read

Press Releases

CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)

November 18, 2024

·

1 min read

Press Releases

CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results

November 15, 2024

·

6 min read

Press Releases

CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment

November 5, 2024

·

1 min read

JOBS